Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
BONAFIDE: Cinacalcet for Bone Histomorphometry in Dialysis Patients
NCT00261950Phase 2Completed
- Sponsor
- Amgen
- Start
- May 2006
- Primary completion
- May 2011
- Modality
- Small Molecules
- Countries
- 12
01
Overview
A Phase 2 trial of cinacalcet in secondary hyperparathyroidism (SHPT), sponsored by Amgen. Started May 2006; status: completed.
02
Drugs
cinacalcet
03
Conditions
secondary hyperparathyroidism (SHPT)
Beyond the preview
Go deeper on NCT00261950.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00261950.